TS
EXAS

Thomas Steyer’s Exact Sciences EXAS Stock Holding History

Thomas Steyer’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,405,000
Closed -$650M – 184
2025
Q4 		$650M Buy
+6,405,000
New +$514M 2.82% 12
2023
Q3 		– Sell
-602,000
Closed -$56.5M – 171
2023
Q2 		$56.5M Buy
+602,000
New +$47M 0.28% 66
2022
Q2 		– Sell
-802,898
Closed -$56.1M – 319
2022
Q1 		$56.1M Buy
802,898
+481,000
+149% +$35.2M 0.27% 67
2021
Q4 		$25.1M Sell
321,898
-275,700
-46% -$24.3M 0.13% 83
2021
Q3 		$57M Buy
597,598
+347,598
+139% +$36.7M 0.27% 71
2021
Q2 		$31.1M Buy
+250,000
New +$29.8M 0.13% 86

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Thomas Steyer's EXAS Position: Q1 2026 in Review

Thomas Steyer sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 6,405,000 shares — an estimated $650M sold.

Thomas Steyer first reported a position in EXAS in Q2 2021 and held it in 6 quarters. The position peaked at $650M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Thomas Steyer reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Thomas Steyer sold 6,405,000 Exact Sciences shares in Q1 2026, an estimated $650M.
  • Thomas Steyer first reported a position in Exact Sciences in Q2 2021 and held it in 6 quarters.
  • Thomas Steyer's Exact Sciences position peaked at $650M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.